Journal of Allergy and Hypersensitivity Diseases

Official publication of the Societe francaise d'allergologie (French society of allergy).



Follow us on X (Twitter): @JAHDJournal, LinkedIn: Journal of Allergy and Hypersensitivity Diseases - JAHD and Facebook: Journal of Allergy and Hypersensitivity Diseases ? JAHD

Scope

The Journal of Allergy and Hypersensitivity Diseases (JAHD) is a peer-reviewed, open-access journal in the fields of allergy and immunology. It covers all aspects of the fields, including clinical, educational, and translational research, associated with new technologies, epidemiology, public health and environmental aspects. JAHD is an international platform for promoting and disseminating findings in quality original articles, guidelines, reviews, and short communications to a wide audience.

Aims

The JAHD supports modern and traditional approaches and public health strategies to improve the quality care of patients with allergy, asthma and hypersensitivity. An international team of experts counts as part of the editorial board and reviewers, who ensure dynamic peer-review and timely high impact scientific publications.

Content

All JAHD content will be peer-reviewed. The journal welcomes original articles covering the spectrum of conditions managed by allergists in clinical practice, such as:

anaphylaxis

drug-related allergy

food and insect sting allergic and hypersensitivity conditions

allergic and hypersensitivity conditions affecting the eyes

skin and respiratory tract conditions

eosinophilic and mast cell disorders

epidemiological, environmental, mechanistic, and diagnostic research

The JAHD will present results from these areas in original papers, review articles and short communications. This research must advance the understanding of an allergic condition or medical treatment and contribute to improving the quality of care of patients with allergy, asthma, and hypersensitivity.

Article types

The JAHD will consider articles, reviews, technical notes and letters to the editors for publication, provided that the methodology and the scientific content are of high quality and the results have substantial clinical impact.

Publication schedule

The journal will be published in e-only format and 2 issues in the first year, 4 issues in the second, third and fourth years, and every 2 months in year 5 and after (6 issues per year). The journal will use a fast production workflow, with article-based publishing and article numbering.

Editorial board and processes

Article quality will be assured by an international and gender-balanced editorial board nominated by the editor-in-chief.